Danielle Landrein joins Dewey Scientific to build and execute on strategic growth plans on the heels of Dewey’s Series A announcement
PULLMAN, Washington, September 9, 2021– Dewey Scientific, a privately-funded agtech innovator pioneering solutions for a sustainable and thriving cannabis industry, announces that Danielle Landrein has joined Dewey Scientific’s leadership team as Chief Growth Officer.
In this role, Danielle will collaborate with our executive team and oversee the execution of Dewey’s business strategies and corporate development activities, drive forward financially sustainable and efficient business operations, and manage and build partnership and investor relationships.
With over 10 years of experience, Danielle has spent a significant portion of her career helping global foundations, national universities, and startups scale. Danielle joins Dewey Scientific from Aether Biomachines, a Silicon Valley biotech startup focused on enzymes for novel chemistries, where she served as Chief of Staff to the CEO, and later, Head of People. There she led investor relations, legal, people, communications and branding, and operationalized countless other aspects of the business, sourcing and overseeing a team of 50+ contractors, vendors, and professional service firms. In her career, she has also held Chief of Staff, Case Team Leader, and Senior Analyst positions at Goldman Sachs, Entangled Solutions, and Sentieo.
“Danielle’s tenacity, entrepreneurial spirit, and empathy approaching client relationships perfectly compliments our values at Dewey Scientific and we are very excited to welcome her to the Dewey team,” said CEO and Co-Founder Jordan Zager, PhD. “Her ability to efficiently solve complex problems and passion for working with companies looking to make an impact on the world will be tremendous assets to reinforce Dewey’s plans to grow our team, bolster our research capabilities, and develop a franchise arm. Danielle’s background supporting these types of initiatives for both startups and Fortune 500 companies adds a unique perspective to our leadership team and we couldn’t be happier to bring her on board.”
Danielle has a diverse range of experience collected throughout her career, beginning with a background in structured finance and legal contract negotiation from her time as a financial analyst at Goldman Sachs. She later moved to Entangled Solutions, a boutique management consulting firm operating in the higher education space, where she polished her project management, management consulting and team leadership skills. Over the last few years, Danielle has worked as Chief of Staff to the CEO, first for Sentineo, then for Aether Biomachines. In these roles she worked on everything from enterprise sales, marketing and fundraising, to investor relationships, strategic planning and founder-driven commercialization.
“I could not be more thrilled to be joining an organization with such industry-leading, peer-reviewed, scientific innovation and rigor,” said Danielle. “Dewey Scientific’s proven track record with respect to maintaining multi-year strategic partnerships is a testament to the value of its genetic research and product. I very much look forward to contributing to Dewey’s growth goals by continuing to build on our strong foundation and exceptional founding team.”
A first-generation college student, Danielle earned her B.A. in Economics from the University of Chicago with honors.
Danielle is the latest of six new hires at Dewey Scientific and three new hires at Dewey Cannabis in 2021. Dewey’s founding team includes three PhDs, including Dr. Mark Lange, a world-renowned expert in terpene biochemistry and natural product biosynthesis. The new hires come on the heels of Dewey Scientific’s Series A announcement last month.
